ASX:OCC

Email Alerts for:
ASX:OCC

Surgical strike: Orthocell's Remplir breaks into Singapore early

12 Dec 2024 - Orthocell (ASX:OCC) has achieved first sales of its peripheral nerve repair product Remplir in Singapore.

Orthocell clears milestone for US launch of Remplir

02 Dec 2024 - Orthocell (ASX:OCC) has completed a pivotal US FDA 510(k) regulatory study for its nerve repair product, Remplir. This paves the way for the submission of a marketing…

Orthocell announces Singapore distribution deal

27 Nov 2024 - Orthocell (ASX:OCC) has appointed Device Technologies Asia as the exclusive distributor of its nerve repair device, Remplir, in Singapore.

Orthocell secures $17m to fund US entry

25 Oct 2024 - Orthocell (ASX:OCC) has secured $17m in a recent capital raising initiative, aimed at funding the US launch of its flagship Remplir device.

Rebound rally: Aus shares close 1.4 per cent higher

29 Sep 2022 - The S&P/ASX 200 enjoyed a rebound today, with the market up 2 per cent in intraday trading, closing 1.44 per cent or 93 points higher at 6555.00. All 11 sectors close…

Resurgent ASX rallies: Aus shares 1.8% higher at noon

29 Sep 2022 - Inflation data out today from the Australian Bureau of Statistics saw inflation rise by 6.8 per cent in the year to August, slightly lower than the 7 per cent recorde…

Stocks of the Hour: Orthocell, Telix Pharmaceuticals, Asra Minerals

21 Jul 2022 - A snapshot of the stocks on the move featuring Orthocell (ASX:OCC), Telix Pharmaceuticals (ASX:TLX) and Asra Minerals (ASX:ASR).

Stellar start for IPO EZZ Life Science (ASX:EZZ): ASX closed 0.8% higher

03 Mar 2021 - It has been a positive day of trade for the Australian share market. At the closing bell the S&P/ASX 200 index closed 56 points up or 0.8% higher to finish at 6,818. …

Flight Centre shares fall on challenging H1 predictions: ASX 0.8% lower at noon

09 Oct 2019 - The ASX opened lower following soft leads from Wall Street and is now tracking 0.8% lower at noon. Cleanaway Waste Management (ASX:CWY) shares shot up after becoming …

Orthocell see 89% of patients return to work pain-free

04 Sep 2019 - Regenerative medicine company Orthocell (ASX:OCC) reports the final results from patients who completed the CelGro® tendon regeneration clinical trial showing 89 per …

Aus shares hit another new fresh high 6,644pts: ASX 1% up at noon

19 Jun 2019 - Most sectors rise up on ASX with ASX200 hitting a new fresh high of 6,644pts. Nanosonics (ASX:NAN) shares hit all-time high on France support. Orthocell (ASX:OCC) pro…

Costa Group wipes out 2 years of gains: Aus shares see red for 2nd day, 0.74% lower

30 May 2019 - ASX ends lower for second day following Wall Street's lead, while Costa Group Holdings (ASX:CGC) selling weighted after its shares lost 27%. Patry’s (ASX:PAB) drug re…

Orthocell (ASX:OCC) bone & soft tissue repair

20 May 2019 - Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson talks about the company's CelGro collagen-based scaffold, sales and distribution, progress with the US FD…

Small cap Orthocell up 360%, TPG & Vodafone merge red lighted: ASX200 closes 0.4% lower

08 May 2019 - Small cap Orthocell (ASX:OCC) shares charge 360% on regenerating damaged nerves and giving patients regained sensation and muscle function again in limbs. Treasury …

Treasury Wine Estates shares take a dip: ASX tracking 0.4 per cent lower at noon

08 May 2019 - The ASX fell at the open and is now tracking 0.4% lower at noon. Shares in regenerative medicine company Orthocell (ASX:OCC) skyrocketed today after announcing the fi…

Orthocell sees four patients benefit from CelGro trial

08 May 2019 - Regenerative medicine company Orthocell (ASX:OCC) have seen the first four patients successfully complete participation in the CelGro® nerve regeneration clinical tri…

Orthocell (ASX:OCC) Presentation, FNN Investor Event, September 2018, Sydney

14 Sep 2018 - Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson presents on advances in regenerative medicine, the company's product line up and commercialisation at FNN…

Orthocell (ASX:OCC) regenerative medicine leader

14 Sep 2018 - Orthocell Limited (ASX:OCC) Managing Director, Paul Anderson talks about advances in regenerative medicine, the company's product line up and commercialisation.

Orthocell granted Singapore patent for ‘CelGro’

28 Mar 2017 - Orthocell Ltd (ASX:OCC) receives additional Singapore patent for its CelGro regenerative medical device.

Out of puff: Aus shares close 0.08% lower

12 Jan 2017 - Out of puff: Aus shares close 0.08% lower. Drone manufacturer IOT Group (ASX:IOT) has responded to media reports relating to allegations of conduct by its subsidiary…

Midday: Aus shares track 0.24% higher at noon

17 Jun 2016 - Aus shares track 0.24% higher at noon. Superloop Limited (ASX:SLC) says it intends to undertake a 1 for 7 pro rata non-renounceable entitlement issue to raise around…

Orthocell announces positive results for CelGro

16 Jun 2016 - Orthocell Limited (ASX:OCC) says that the pilot study for its product, CelGro, has shown no complications in patients so far.

Orthocell wins US patent

07 Jan 2016 - Orthocell Limited (ASX:OCC) has won a US patent for its ‘cell factory’ technology which helps in tissue growth and regeneration.

Orthocell key patent granted in Canada

09 Dec 2015 - Orthocell Limited (ASX:OCC) has announced it has been granted a patent in Canada.

Midday: ASX selloff on Chinese plunge

09 Jul 2015 - ASX selloff on Chinese plunge. Orthocell Limited (ASX:OCC) receives a $430,000 grant to progress its laboratory grown tendon project.